猪胆粉有效成分 HDCA通过调控肠道胆汁酸代谢抑制胆固醇结石形成的实验研究OA
Experimental study on the inhibition of cholesterol gallstone forma-tion by HDCA,the active component of Pulvis Fellis Suis,through reg-ulation of intestinal bile acid metabolism
目的:探究猪去氧胆酸(hyodeoxycholic acid,HDCA)通过调控肠道胆汁酸代谢,影响法尼醇X受体(farnesoid X receptor,FXR)活性,抑制胆固醇结石生成.方法:将C57BL/6J小鼠随机分成对照组、胆固醇结石模型组、猪胆粉(pulvis fel-lis suis,PFS)(7%、10%)给药干预组,每组 6只;将C57BL/6J小鼠随机分成对照组、胆固醇结石模型组、HDCA(0.1%、0.5%、1%)给药干预组,每组6只;对各组小鼠进行称重、拍照、收集各组织样本并进行胆囊结石等级评估;用总胆固醇(T-CHO)检测试剂盒和酶标仪检测样本中总胆固醇的含量;在体外细胞实验方面,通过实时定量聚合酶链反应(qPCR)分析 HDCA对肠道细胞中FXR的直接调节作用;使用 16S核糖体RNA(16S ribosomal RNA,16S rRNA)测序技术检测各组小鼠粪便菌群的变化差异;液相色谱-质谱法(liq-uid chromatography-mass spectrometry,LC-MS/MS)测定回肠组织中胆汁酸池的变化.结果:与模型组相比,10%PFS和 1%HDCA给药干预组均显著降低小鼠胆囊胆固醇结石等级和血清胆固醇含量(P<0.01),并且 1%HDCA组显著降低小鼠肝重与体质量的比值和肝脏胆固醇含量(P<0.01);在体外实验中,HDCA显著降低肠道细胞 Caco-2中 FXR的相对表达量(P<0.05、P<0.01);HDCA显著降低疣微菌门(Verrucomi-crobiota与激活FXR型胆汁酸呈显著正相关)的含量(P<0.05),显著升高拟杆菌门(Bacteroido-ta与激活FXR型胆汁酸呈显著负相关)的含量(P<0.01);并且HDCA显著改变肠道胆汁酸成分,降低激活FXR型胆汁酸含量占比,升高抑制FXR型胆汁酸含量占比(P<0.05).结论:HD-CA可能通过调节肠道菌群提高抑制FXR型胆汁酸的含量,从而间接发挥抑制肠道FXR,促进胆汁酸合成且降低胆固醇饱和度的作用,达到抑制胆固醇结石形成的效果.
AIM:To explore how hyodeoxycholic acid(HDCA)regulates intestinal bile acid metabolism and thereby modulates the activity of farnesoid X receptor(FXR)to inhibit the formation of cholesterol gallstones.METHODS:The C57BL/6J mice were randomly divided into a control group,a cholesterol gallstone model group,and a Pulvis fel-lis suis(PFS)(7%,10%)administration intervention group(6 mice in each group).The C57BL/6J mice were also randomly divided into a control group,a cholesterol gallstone model group,and HDCA(0.1%,0.5%,1%)administration intervention groups(6 mice in each group).The mice in each group were weighed,photographed,and tissue samples were collected for gallstone grade assessment.The total cholesterol(T-CHO)content in the samples was de-tected using a total cholesterol detection kit and a microplate reader.In the in vitro cell experiments,the direct regulatory effect of HDCA on FXR in in-testinal cells was analyzed by quantitative poly-merase chain reaction(qPCR).The differences in fe-cal microbiota among the groups were detected us-ing 16S ribosomal RNA(16S rRNA)sequencing tech-nology.The changes in the bile acid pool in the ileum tissue were determined by liquid chromatog-raphy-mass spectrometry(LC-MS/MS).RESULTS:Compared with the model group,both the 10%PFS and 1%HDCA intervention groups significantly re-duced the grade of cholesterol gallstones in the gallbladder and the serum cholesterol content of mice(P<0.01),and the 1%HDCA group significantly decreased the ratio of liver weight to body weight and the cholesterol content in the liver of mice(P<0.01);in the in vitro experiments,HDCA signifi-cantly reduced the relative expression level of FXR in intestinal cells Caco-2(P<0.05,P<0.01);HDCA sig-nificantly reduced the content of the Verrucomicro-biota(which was significantly positively correlated with activated FXR-type bile acids)(P<0.05)and sig-nificantly increased the content of the Bacteroidota(which was significantly negatively correlated with activated FXR-type bile acids)(P<0.01).Moreover,HDCA significantly changed the composition of in-testinal bile acids,reducing the proportion of acti-vated FXR-type bile acids and increasing the propor-tion of inhibitory FXR-type bile acids(P<0.05).CON-CLUSION:HDCA may increase the inhibition of FXR-type bile acids by regulating the intestinal flora,thereby indirectly exerting the effect of inhibiting intestinal FXR,promoting bile acid synthesis and re-ducing cholesterol saturation,and achieving the goal of inhibiting the formation of cholesterol gall-stones.
苏英洋;邓妍;刘星羽;杜玉珍;宁敏;吴姗;吴凯悦;沈双
上海海洋大学水产与生命学院,上海 201306||上海交通大学医学院附属第六人民医院,上海 201306上海海洋大学水产与生命学院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306上海交通大学医学院附属第六人民医院,上海 201306||上海健康医学院附属第六人民医院,上海 201306
医药卫生
猪去氧胆酸猪胆粉法尼醇X受体胆汁酸胆固醇结石
hyodeoxycholic acidPulvis Fellis Suisfarnesoid X receptorbile acidscholesterol gall-stones
《中国临床药理学与治疗学》 2026 (8)
1016-1026,11
国家自然科学基金项目(82200710)上海健康医学院校院协同合作重点项目(XJJJ2503-6)
评论